- Home
- BWBBP vs VCEL Comparison
BWBBP vs VCEL Comparison
Compare BWBBP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWBBP
- VCEL
- Stock Information
- Founded
- BWBBP N/A
- VCEL 1989
- Country
- BWBBP United States
- VCEL United States
- Employees
- BWBBP 290
- VCEL N/A
- Industry
- BWBBP Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWBBP Finance
- VCEL Health Care
- Exchange
- BWBBP Nasdaq
- VCEL Nasdaq
- Market Cap
- BWBBP N/A
- VCEL 2.1B
- IPO Year
- BWBBP N/A
- VCEL 1997
- Fundamental
- Price
- BWBBP $18.58
- VCEL $40.15
- Analyst Decision
- BWBBP
- VCEL Strong Buy
- Analyst Count
- BWBBP 0
- VCEL 8
- Target Price
- BWBBP N/A
- VCEL $62.00
- AVG Volume (30 Days)
- BWBBP N/A
- VCEL 430.8K
- Earning Date
- BWBBP N/A
- VCEL 07-31-2025
- Dividend Yield
- BWBBP N/A
- VCEL N/A
- EPS Growth
- BWBBP N/A
- VCEL 521.85
- EPS
- BWBBP N/A
- VCEL 0.05
- Revenue
- BWBBP N/A
- VCEL $238,541,000.00
- Revenue This Year
- BWBBP N/A
- VCEL $23.03
- Revenue Next Year
- BWBBP N/A
- VCEL $24.52
- P/E Ratio
- BWBBP N/A
- VCEL $705.61
- Revenue Growth
- BWBBP N/A
- VCEL 14.80
- 52 Week Low
- BWBBP N/A
- VCEL $37.39
- 52 Week High
- BWBBP N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BWBBP 49.17
- VCEL 44.33
- Support Level
- BWBBP $18.43
- VCEL $40.53
- Resistance Level
- BWBBP $18.56
- VCEL $43.57
- Average True Range (ATR)
- BWBBP 0.10
- VCEL 1.62
- MACD
- BWBBP 0.01
- VCEL -0.16
- Stochastic Oscillator
- BWBBP 77.39
- VCEL 28.65
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.